LOUD Capital
Venture capitalColumbus · Pre-Seed–Growth · 6 people tracked
Investment thesis
LOUD Ventures reimagines venture capital for healthcare by combining patient-centric impact with investment returns. Rather than passive capital deployment, the firm embeds clinicians, operators, and financial expertise directly into portfolio companies to accelerate healthcare innovation from discovery to delivery. The firm designs flexible funding structures, operates through the LOUD Collective platform to provide infrastructure and operational support, and measures success by both financial returns and measurable improvements in patient access, outcomes, and efficiency.
Source: firm website, verified Aug 6, 2026.
Team · 6 people
from public directoriesFrequently asked questions
- What stage does LOUD Capital invest at?
- LOUD Capital invests at the Pre-Seed, Seed, Series A, Growth stages.
- What sectors does LOUD Capital focus on?
- LOUD Capital focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is LOUD Capital located?
- LOUD Capital is headquartered in Columbus, US.
Images
Co-investors · 1
Zeal Capital Partners is an early-stage venture firm backing founders building companies across fintech, healthcare, and the future of learning and work, with a focus on closing gaps in wealth, health, and skills.
Firms observed investing alongside LOUD Capital, from public investor directories. Shared companies are the overlap with LOUD Capital's recorded portfolio.
Similar investors
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
MaRS is a Toronto-based innovation hub and accelerator that supports Canadian startups from pre-seed funding through international expansion, offering workspace, mentorship, investor and customer connections, and sector-focused programming.



